Karyopharm Therapeutics Inc’s recent filing unveils that its EVP, Chief Development Officer Poulton Stuart unloaded Company’s shares for reported $3726.0 on Feb 18 ’25. In the deal valued at $0.63 per share,5,914 shares were sold. As a result of this transaction, Poulton Stuart now holds 320,714 shares worth roughly $0.18 million.
Then, Paulson Richard A. sold 4,099 shares, generating $2,664 in total proceeds. Upon selling the shares at $0.65, the President and CEO now owns 1,120,158 shares.
Before that, Paulson Richard A. sold 4,055 shares. Karyopharm Therapeutics Inc shares valued at $3,175 were divested by the President and CEO at a price of $0.78 per share. As a result of the transaction, Paulson Richard A. now holds 1,124,257 shares, worth roughly $0.64 million.
Piper Sandler initiated its Karyopharm Therapeutics Inc [KPTI] rating to an Overweight in a research note published on January 19, 2023; the price target was $8. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who increased its forecast for the stock in early November from “a Sector perform” to “an Outperform”. JP Morgan also remained covering KPTI and has increased its forecast on February 09, 2022 with a “Neutral” recommendation from previously “an Underweight” rating.
Price Performance Review of KPTI
On Tuesday, Karyopharm Therapeutics Inc [NASDAQ:KPTI] saw its stock fall -4.10% to $0.57. Over the last five days, the stock has lost -9.38%. Karyopharm Therapeutics Inc shares have fallen nearly -15.58% since the year began. Nevertheless, the stocks have fallen -49.48% over the past one year. While a 52-week high of $1.70 was reached on 01/06/25, a 52-week low of $0.51 was recorded on 02/24/25. SMA at 50 days reached $0.6629, while 200 days put it at $0.8264.
Levels Of Support And Resistance For KPTI Stock
The 24-hour chart illustrates a support level at 0.5506, which if violated will result in even more drops to 0.5303. On the upside, there is a resistance level at 0.5956. A further resistance level may holdings at 0.6203. The Relative Strength Index (RSI) on the 14-day chart is 37.39, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0259, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 64.25%. Stochastics %K at 43.13% indicates the stock is a holding.
